| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Nipaporn Muangchan, Benjapa Khiewvan, Saimai Chatree, Kitchaya Pongwattanapakin, Nattinee Kunlaket, Traiphop Dokmai, Reawika Chaikomi. Riceberry rice ( The British journal of nutrition. 2021-10-01. PMID:34503597. |
this study aimed to evaluate the acute effect of ingesting riceberry rice (rr) compared with that of ingesting white rice (wr) on gastric emptying rate (ger), plasma glucose and glucose-regulating hormones, including insulin, glucose-dependent insulinotropic polypeptide (gip) and glucagon-like peptide 1 (glp-1), in healthy subjects. |
2021-10-01 |
2023-08-13 |
human |
| Nipaporn Muangchan, Benjapa Khiewvan, Saimai Chatree, Kitchaya Pongwattanapakin, Nattinee Kunlaket, Traiphop Dokmai, Reawika Chaikomi. Riceberry rice ( The British journal of nutrition. 2021-10-01. PMID:34503597. |
ger was measured by scintigraphy over 240 min, and plasma concentrations of glucose, insulin, glp-1 and gip were measured at multiple time points over 180 min. |
2021-10-01 |
2023-08-13 |
human |
| Nipaporn Muangchan, Benjapa Khiewvan, Saimai Chatree, Kitchaya Pongwattanapakin, Nattinee Kunlaket, Traiphop Dokmai, Reawika Chaikomi. Riceberry rice ( The British journal of nutrition. 2021-10-01. PMID:34503597. |
plasma insulin and glp-1 concentrations did not differ between rr and wr. |
2021-10-01 |
2023-08-13 |
human |
| Nipaporn Muangchan, Benjapa Khiewvan, Saimai Chatree, Kitchaya Pongwattanapakin, Nattinee Kunlaket, Traiphop Dokmai, Reawika Chaikomi. Riceberry rice ( The British journal of nutrition. 2021-10-01. PMID:34503597. |
we conclude that rr attenuates postprandial glycaemia by slowing ger without altering plasma insulin or glp-1. |
2021-10-01 |
2023-08-13 |
human |
| Gianmarco Ferri, Marta Tesi, Luca Pesce, Marco Bugliani, Francesca Grano, Margherita Occhipinti, Mara Suleiman, Carmela De Luca, Lorella Marselli, Piero Marchetti, Francesco Cardarell. Spatiotemporal Correlation Spectroscopy Reveals a Protective Effect of Peptide-Based GLP-1 Receptor Agonism against Lipotoxicity on Insulin Granule Dynamics in Primary Human β-Cells. Pharmaceutics. vol 13. issue 9. 2021-10-01. PMID:34575477. |
spatiotemporal correlation spectroscopy reveals a protective effect of peptide-based glp-1 receptor agonism against lipotoxicity on insulin granule dynamics in primary human β-cells. |
2021-10-01 |
2023-08-13 |
human |
| Samar Y Ahmad, James K Friel, Dylan S MacKa. The effect of the artificial sweeteners on glucose metabolism in healthy adults: a randomized, double-blinded, crossover clinical trial. Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme. vol 45. issue 6. 2021-09-28. PMID:31697573. |
blood samples were collected and analyzed for glucose, insulin, active glucagon-like peptide-1 (glp-1), and leptin. |
2021-09-28 |
2023-08-13 |
human |
| Qiu-Xuan Li, Han Gao, Yue-Xin Guo, Bo-Ya Wang, Rong-Xuan Hua, Lei Gao, Hong-Wei Shang, Xin Lu, Jing-Dong X. GLP-1 and Underlying Beneficial Actions in Alzheimer's Disease, Hypertension, and NASH. Frontiers in endocrinology. vol 12. 2021-09-25. PMID:34552561. |
since its discovery, glp-1 has emerged as an incretin hormone for its facilitation in insulin release and reduction of insulin resistance (ir). |
2021-09-25 |
2023-08-13 |
Not clear |
| Alexander Dimitri Miras, Anna Kamocka, Belén Pérez-Pevida, Sanjay Purkayastha, Krishna Moorthy, Ameet Patel, Harvinder Chahal, Gary Frost, Paul Bassett, Lidia Castagnetto-Gissey, Lucy Coppin, Nicola Jackson, Anne Margot Umpleby, Stephen Robert Bloom, Tricia Tan, Ahmed Rashid Ahmed, Francesco Rubin. The Effect of Standard Versus Longer Intestinal Bypass on GLP-1 Regulation and Glucose Metabolism in Patients With Type 2 Diabetes Undergoing Roux-en-Y Gastric Bypass: The Long-Limb Study. Diabetes care. vol 44. issue 5. 2021-09-22. PMID:33158945. |
we hypothesized that if this is the predominant mechanism behind the enhanced secretion of glp-1, a longer intestinal bypass would potentiate the postprandial peak in glp-1, translating into higher insulin secretion and, thus, additional improvements in glucose tolerance. |
2021-09-22 |
2023-08-13 |
Not clear |
| Melissa K Thomas, Amir Nikooienejad, Ross Bray, Xuewei Cui, Jonathan Wilson, Kevin Duffin, Zvonko Milicevic, Axel Haupt, Deborah A Robin. Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes. The Journal of clinical endocrinology and metabolism. vol 106. issue 2. 2021-09-20. PMID:33236115. |
dual gip and glp-1 receptor agonist tirzepatide improves beta-cell function and insulin sensitivity in type 2 diabetes. |
2021-09-20 |
2023-08-13 |
Not clear |
| Sherry A Ferguson, John J Panos, Daniel Sloper, Vijayalakshmi Varma, Sumit Sarka. Alzheimer's disease: a step closer to understanding type 3 diabetes in African Americans. Metabolic brain disease. vol 36. issue 7. 2021-09-20. PMID:34021875. |
additionally, we measured levels of c-peptide, ghrelin, gastric inhibitory polypeptide (gip), glucagon-like peptide-1 (glp-1), glucagon, insulin, leptin, pai-1, resistin, and visfatin using a human diabetes 10-plex assay. |
2021-09-20 |
2023-08-13 |
human |
| Sherry A Ferguson, John J Panos, Daniel Sloper, Vijayalakshmi Varma, Sumit Sarka. Alzheimer's disease: a step closer to understanding type 3 diabetes in African Americans. Metabolic brain disease. vol 36. issue 7. 2021-09-20. PMID:34021875. |
all measures in the diabetes disease panel assay were significantly elevated in african americans: ghrelin, gip, glp-1, glucagon, insulin, and visfatin. |
2021-09-20 |
2023-08-13 |
human |
| Kim K B Clemmensen, Jonas S Quist, Dorte Vistisen, Daniel R Witte, Anna Jonsson, Oluf Pedersen, Torben Hansen, Jens J Holst, Torsten Lauritzen, Marit E Jørgensen, Signe Torekov, Kristine Færc. Role of fasting duration and weekday in incretin and glucose regulation. Endocrine connections. vol 9. issue 4. 2021-09-17. PMID:32163918. |
linear regression analysis was applied to study the associations of overnight fasting duration and day of the week with glucose, insulin, glucagon, glucose-dependent insulinotropic polypeptide (gip) and glucagon-like peptide 1 (glp-1) responses to an ogtt. |
2021-09-17 |
2023-08-13 |
human |
| Yoshikatsu Saitoh, Akiko Inagaki, Ibrahim Fathi, Takehiro Imura, Hiroyasu Nishimaki, Hiroyuki Ogasawara, Muneyuki Matsumura, Shigehito Miyagi, Yohichi Yasunami, Michiaki Unno, Takashi Kamei, Masafumi Got. Improvement of hepatocyte engraftment by co-transplantation with pancreatic islets in hepatocyte transplantation. Journal of tissue engineering and regenerative medicine. vol 15. issue 4. 2021-09-14. PMID:33484496. |
although insulin, vegf, and glp-1 were selected as candidate crucial factors using the bio-plex system, beneficial effects were partially counteracted by anti-insulin receptor antibodies. |
2021-09-14 |
2023-08-13 |
rat |
| Nazia Siddiqui, Javed Ali, Suhel Parvez, Saima Zameer, Abul Kalam Najmi, Mohd Akhta. Linagliptin, a DPP-4 inhibitor, ameliorates Aβ (1-42) peptides induced neurodegeneration and brain insulin resistance (BIR) via insulin receptor substrate-1 (IRS-1) in rat model of Alzheimer's disease. Neuropharmacology. vol 195. 2021-09-13. PMID:34119519. |
linagliptin, a dpp-4 inhibitor is hypothesized to increase glp-1 level, which then crosses blood brain barrier (bbb), decreases amyloid-beta (aβ) and insulin resistance in hippocampus. |
2021-09-13 |
2023-08-13 |
rat |
| Eline Birkeland, Sedegheh Gharagozlian, Hanne L Gulseth, Kåre I Birkeland, Bolette Hartmann, Jens J Holst, René Holst, Anne-Marie Aa. Effects of prebiotics on postprandial GLP-1, GLP-2 and glucose regulation in patients with type 2 diabetes: A randomised, double-blind, placebo-controlled crossover trial. Diabetic medicine : a journal of the British Diabetic Association. vol 38. issue 10. 2021-09-10. PMID:34297363. |
we aimed to investigate the effect of prebiotic inulin-type fructans (itf) versus a control supplement on postprandial levels of glucagon-like peptide-1 and -2 (glp-1 and -2), glucose and insulin in people with type 2 diabetes. |
2021-09-10 |
2023-08-13 |
Not clear |
| Jicheng Yu, Yuqi Zhang, Hunter Bomba, Zhen G. Stimuli-Responsive Delivery of Therapeutics for Diabetes Treatment. Bioengineering & translational medicine. vol 1. issue 3. 2021-09-09. PMID:29147685. |
diabetic therapeutics, including insulin and glucagon-like peptide 1 (glp-1), are essential for diabetic patients to regulate blood glucose levels. |
2021-09-09 |
2023-08-13 |
Not clear |
| Lawrence Blonde, Julio Rosenstock, Juan Frias, Andreas L Birkenfeld, Elisabeth Niemoeller, Elisabeth Souhami, Chen Ji, Stefano Del Prato, Vanita R Arod. Durable Effects of iGlarLixi Up to 52 Weeks in Type 2 Diabetes: The LixiLan-G Extension Study. Diabetes care. vol 44. issue 3. 2021-09-09. PMID:33468520. |
in the lixilan-g trial, switching to iglarlixi, a once-daily titratable fixed-ratio combination of insulin glargine 100 units/ml and the glucagon-like peptide 1 receptor agonist (glp-1 ra) lixisenatide, improved glucose control in type 2 diabetes uncontrolled with glp-1 ras over 26 weeks versus continuing prior glp-1 ra. |
2021-09-09 |
2023-08-13 |
Not clear |
| Jos F M L Seegers, Ismail Sahin Gül, Stijn Hofkens, Sonja Brosel, Gudrun Schreib, Jara Brenke, Claudia Donath, Willem M de Vo. Toxicological safety evaluation of live Anaerobutyricum soehngenii strain CH106. Journal of applied toxicology : JAT. 2021-09-09. PMID:34184753. |
a recent human intervention provided support for the mode of action of a. soehngenii as it affected gene expression in the duodenum, stimulated the secretion of glp-1 and improved insulin sensitivity. |
2021-09-09 |
2023-08-13 |
human |
| Alex Abramson, Morten Revsgaard Frederiksen, Andreas Vegge, Brian Jensen, Mette Poulsen, Brian Mouridsen, Mikkel Oliver Jespersen, Rikke Kaae Kirk, Jesper Windum, František Hubálek, Jorrit J Water, Johannes Fels, Stefán B Gunnarsson, Adam Bohr, Ellen Marie Straarup, Mikkel Wennemoes Hvitfeld Ley, Xiaoya Lu, Jacob Wainer, Joy Collins, Siddartha Tamang, Keiko Ishida, Alison Hayward, Peter Herskind, Stephen T Buckley, Niclas Roxhed, Robert Langer, Ulrik Rahbek, Giovanni Travers. Oral delivery of systemic monoclonal antibodies, peptides and small molecules using gastric auto-injectors. Nature biotechnology. 2021-09-09. PMID:34462588. |
we administered the capsules to swine for delivery of clinically relevant doses of four commonly injected medications, including adalimumab, a glp-1 analog, recombinant human insulin and epinephrine. |
2021-09-09 |
2023-08-13 |
human |
| Remi Kamakura, Ghulam Shere Raza, Aishwarya Prasannan, Jaroslaw Walkowiak, Karl-Heinz Herzi. Dipeptidyl peptidase-4 and GLP-1 interplay in STC-1 and GLUTag cell lines. Peptides. vol 134. 2021-09-08. PMID:32998057. |
glp-1 plays a major role in gut motility, appetite regulation, and insulin secretion. |
2021-09-08 |
2023-08-13 |
human |